Literature DB >> 27548374

Recovering Infectious HIV from Novel Syringe-Needle Combinations with Low Dead Space Volumes.

Nadia Abdala1, Amisha Patel1, Robert Heimer1.   

Abstract

This study determines if detachable syringe-needle combinations redesigned to reduce their dead space volume may substantially reduce the burden of exposure to infectious HIV among people who inject drugs. Two novel, low dead space (LDS) syringe-needle designs-one added a piston to the plunger (LDS syringe) and the other added a filler to the needle (LDS needle) to reduce their dead space-were compared to standard detachable needle-syringe combinations and to syringes with fixed needles. LDS and standard syringes attached to LDS and standard needles of 23-, 25-, and 27-gauge size were contaminated with HIV-infected blood in the laboratory. The proportion of syringe-needle combinations containing infectious HIV was analyzed after syringes were (1) stored up to 7 days at 22°C or (2) rinsed with water. Detachable syringes attached to 25-gauge needles yielded comparable proportions of syringes with infectious HIV, whether the needle was standard or LDS. Among needles of greater diameter (23 gauge), LDS needles tended to reduce recoverable HIV to a greater extent than standard needles. Syringes with fixed needles showed superior results to LDS syringes attached to needles of equivalent diameter and were less likely to get clogged by blood. Detachable LDS syringe-needle designs must be recommended with caution since they still pose potential risk for HIV transmission. Distribution of LDS syringes and needles must be accompanied by recommendations and instructions for their proper rinsing and disinfection in order to reduce viral burden and chances of needle clogging.

Entities:  

Keywords:  HIV viability; infectious HIV; injection drug use; low dead space syringes; syringe clogging; syringe rinsing

Mesh:

Year:  2016        PMID: 27548374      PMCID: PMC5067877          DOI: 10.1089/aid.2016.0023

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  29 in total

1.  Survival of HIV-1 in syringes: effects of temperature during storage.

Authors:  N Abdala; R Reyes; J M Carney; R Heimer
Journal:  Subst Use Misuse       Date:  2000-08       Impact factor: 2.164

2.  Can HIV-1-contaminated syringes be disinfected? Implications for transmission among injection drug users.

Authors:  N Abdala; A A Gleghorn; J M Carney; R Heimer
Journal:  J Acquir Immune Defic Syndr       Date:  2001-12-15       Impact factor: 3.731

3.  Use of bleach to disinfect HIV-1 contaminated syringes.

Authors:  N Abdala; A Gleghorn; J M Carney; R Heimer
Journal:  Am Clin Lab       Date:  2001-07

4.  Explaining the geographical variation of HIV among injection drug users in the United States.

Authors:  D Ciccarone; P Bourgois
Journal:  Subst Use Misuse       Date:  2003-12       Impact factor: 2.164

5.  HIV risk behavior in drug users: increased blood "booting" during cocaine injection.

Authors:  L Greenfield; G E Bigelow; R K Brooner
Journal:  AIDS Educ Prev       Date:  1992

6.  Feasibility of one-time use of sterile syringes: a study of active injection drug users in seven United States metropolitan areas.

Authors:  A A Gleghorn; L Wright-De Agüero; C Flynn
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998

Review 7.  Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward.

Authors:  Daniel Wolfe; M Patrizia Carrieri; Donald Shepard
Journal:  Lancet       Date:  2010-07-31       Impact factor: 79.321

8.  Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial.

Authors:  Jessica M Fogel; Sarah E Hudelson; San-San Ou; Stephen Hart; Carole Wallis; Mariza G Morgado; Shanmugam Saravanan; Srikanth Tripathy; Laura Hovind; Estelle Piwowar-Manning; Devin Sabin; Marybeth McCauley; Theresa Gamble; Xinyi C Zhang; Joseph J Eron; Joel E Gallant; Johnstone Kumwenda; Joseph Makhema; Nagalingeswaran Kumarasamy; Suwat Chariyalertsak; James Hakim; Sharlaa Badal-Faesen; Victor Akelo; Mina C Hosseinipour; Breno R Santos; Sheela V Godbole; Jose H Pilotto; Beatriz Grinsztejn; Ravindre Panchia; Kenneth H Mayer; Ying Q Chen; Myron S Cohen; Susan H Eshleman
Journal:  J Acquir Immune Defic Syndr       Date:  2016-07-01       Impact factor: 3.731

9.  Can home-made injectable opiates contribute to the HIV epidemic among injection drug users in the countries of the former Soviet Union?

Authors:  Nadia Abdala; Jean-Paul C Grund; Yanis Tolstov; Andrei P Kozlov; Robert Heimer
Journal:  Addiction       Date:  2006-05       Impact factor: 6.526

10.  Survival of human immunodeficiency virus type 1 after rinsing injection syringes with different cleaning solutions.

Authors:  Nadia Abdala; Michelle Crowe; Yanis Tolstov; Robert Heimer
Journal:  Subst Use Misuse       Date:  2004-03       Impact factor: 2.164

View more
  5 in total

1.  Detachable low dead space syringes for the prevention of hepatitis C among people who inject drugs in Bristol, UK: an economic evaluation.

Authors:  Elizabeth Hancock; Zoe Ward; Rachel Ayres; Jane Neale; Deborah Hussey; Joanna May Kesten; Matthew Hickman; Peter Vickerman
Journal:  Addiction       Date:  2019-11-19       Impact factor: 6.526

2.  Usage of low dead space syringes and association with hepatitis C prevalence amongst people who inject drugs in the UK.

Authors:  Adam Trickey; Margaret T May; Vivian Hope; Zoe Ward; Monica Desai; Ellen Heinsbroek; Matthew Hickman; Peter Vickerman
Journal:  Drug Alcohol Depend       Date:  2018-09-15       Impact factor: 4.492

3.  Feasibility of needle and syringe programs in Tajikistan distributing low dead space needles.

Authors:  William A Zule; Alisher Latypov; David Otiashvili; Steffani Bangel; Georgiy V Bobashev
Journal:  Harm Reduct J       Date:  2018-08-31

4.  Options for reducing HIV transmission related to the dead space in needles and syringes.

Authors:  William A Zule; Poonam G Pande; David Otiashvili; Georgiy V Bobashev; Samuel R Friedman; V Anna Gyarmathy; Don C Des Jarlais
Journal:  Harm Reduct J       Date:  2018-01-15

5.  Reducing harm through the development of good preparation practices for the injection of slow release morphine sulphate capsules.

Authors:  Lenneke Keijzer
Journal:  Harm Reduct J       Date:  2020-07-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.